Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Shanghai Stock Exchange 600613.SS

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Free Cash Flow for the year ending December 31, 2023: USD 26.91 M

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Free Cash Flow is USD 26.91 M for the year ending December 31, 2023, a -36.52% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Free Cash Flow for the year ending December 31, 2022 was USD 42.40 M, a 174.06% change year over year.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Free Cash Flow for the year ending December 31, 2021 was USD 15.47 M, a 3,517.89% change year over year.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Free Cash Flow for the year ending December 31, 2020 was USD 427.62 K, a -94.20% change year over year.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Free Cash Flow for the year ending December 31, 2019 was USD 7.37 M, a 32.40% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shanghai Stock Exchange: 600613.SS

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

CEO	Mr. Feng Bin
IPO Date	Aug. 20, 1992
Location	China
Headquarters	Changfa Tower
Employees	1,426
Sector	Health Care
Industries Pharmaceuticals

Description

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, tonic products, cold and cough, children's medicine, and anti-fungal drugs. Its products include prescription drugs and OTC products. The company was founded in 1992 and is based in Shanghai, China.

Key trends

Past 5 years